Oxethazaine (Oxetacaine) 是芬特明的酸性前体,是一种具有耐酸性和口服活性的镇痛试剂。Oxethazaine (Oxetacaine) 具有缓解消化性溃疡疾病或食管炎引起的疼痛的潜力。
Oxetacaine (intraperitoneal injection; 5, 10, and 15 mg/kg; during days 4–11) doses induces significant conditioned place preference (CPP), and there are no differences among the groups. While its postive control group phentermine only 3 mg/kg causes significant CPP..
|
Animal Model:
|
Male Wistar rats
|
|
Dosage:
|
5, 10, and 15 mg/kg; during days 4–11
|
|
Administration:
|
Intraperitoneal injection
|
|
Result:
|
Showed a significant CPP in vivo.
|